Triplet Therapeutics

Triplet Therapeutics is developing a fundamentally different approach to treating repeat expansion disorders, including Huntington's disease, myotonic dystrophy, and spinocerebellar ataxia, by addressing the root cause of the genetic dysfunction that triggers disease onset and progression. To achieve this, we have assembled a team with decades of expertise in drug discovery, genetics, clinical research, and operations.